The aim of the Juvenile Diabetes Cure Alliance is to see a Practical Cure for type 1 diabetes become widely available in the next 15 years.
-
JDCA COMMUNITY SIZE. MEMBERS, DONORS, VOLUNTEERS
400,000
-
T1D FREE REPORTS PUBLISHED
500+
-
# OF YEARS PUBLISHING THE DEFINITIVE STATE OF THE CURE FOR T1D
9
-
MORE-FOR-A-T1D-CURE PETITION SIGNATURES
376,000
Latest Research & Reports
Teplizumab, which will go to market by the brand name Tzield, is the first ever disease-modifying therapy for T1D approved by the FDA
This is the 11th annual report of advertising messaging used by JDRF and the ADA to promote national fundraising events.
This is the 11th annual report analyzing the research grant funding by the Juvenile Diabetes Research Foundation (JDRF).
Why we continue advocating for a T1D cure everyday...
-
Voices of the Cure Petition
"I signed for my Granddaughter Addison. Our world is a brighter place with her in it. She is such a trooper with everything she has gone through and she knows so much about her disease. Praying for a cure, as this is such a horrible disease" -- Renee B.
Subscribe for the Latest T1D Practical Cure News & Analysis
Join the mailing list!
When you join our email list, you'll be the first to hear all the latest T1D Practical Cure news.
